TREATMENT RESISTANT BIPOLAR DEPRESSION
Clinical trials for TREATMENT RESISTANT BIPOLAR DEPRESSION explained in plain language.
Never miss a new study
Get alerted when new TREATMENT RESISTANT BIPOLAR DEPRESSION trials appear
Sign up with your email to follow new studies for TREATMENT RESISTANT BIPOLAR DEPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new oral ketamine capsule ease bipolar depression when other treatments fail?
Symptom relief Not yet recruitingThis study tests an oral ketamine capsule (KET-AD) designed to be abuse-deterrent in adults with treatment-resistant bipolar depression. About 160 participants will receive either KET-AD or a placebo, taken three times a week for up to 7 weeks, alongside their usual treatment. Th…
Matched conditions: TREATMENT RESISTANT BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Neurocentrx Pharma Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can ketamine plus therapy curb suicidal thoughts? new trial aims to find out.
Symptom relief Not yet recruitingThis study tests whether combining ketamine infusions with dialectical behavioural therapy (DBT) can reduce suicidal thoughts more effectively than a placebo plus DBT. About 120 adults with borderline personality disorder and treatment-resistant depression or bipolar disorder wil…
Matched conditions: TREATMENT RESISTANT BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC